1. Home
  2. SLDB vs GOOS Comparison

SLDB vs GOOS Comparison

Compare SLDB & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$8.70

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Canada Goose Holdings Inc. Subordinate Voting Shares

GOOS

Canada Goose Holdings Inc. Subordinate Voting Shares

HOLD

Current Price

$7.93

Market Cap

931.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDB
GOOS
Founded
2013
1957
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
931.6M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
SLDB
GOOS
Price
$8.70
$7.93
Analyst Decision
Strong Buy
Hold
Analyst Count
11
5
Target Price
$16.36
$12.60
AVG Volume (30 Days)
751.6K
712.4K
Earning Date
05-12-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
34.97
N/A
EPS
N/A
N/A
Revenue
$8,094,000.00
N/A
Revenue This Year
N/A
$12.21
Revenue Next Year
N/A
$5.16
P/E Ratio
N/A
$75.22
Revenue Growth
N/A
N/A
52 Week Low
$3.79
$7.59
52 Week High
$11.45
$14.69

Technical Indicators

Market Signals
Indicator
SLDB
GOOS
Relative Strength Index (RSI) 45.19 27.33
Support Level $6.25 N/A
Resistance Level $11.45 $10.42
Average True Range (ATR) 0.42 0.24
MACD -0.06 -0.04
Stochastic Oscillator 14.18 3.28

Price Performance

Historical Comparison
SLDB
GOOS

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares

Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale; Direct to Consumer (DTC), and Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia-Pacific, and Europe, the Middle East, and Africa.

Share on Social Networks: